PCRX EBITDA Margin
Pacira Biosciences Inc · EBITDA Margin
PCRX EBITDA Margin
Latest reported13.30%period ending
PCRX Quarterly EBITDA Margin (-137.18% → 13.30%)
Quarterly ebitda margin
High-resolution chart · PNG
PCRX ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 13.3036% | |
| 16.6353% | |
| 12.8433% | |
| 19.1448% | |
| 16.1464% | |
| 19.896% | |
| 27.0239% | |
| -68.0738% | |
| 32.8991% | |
| 20.7645% | |
| 30.2951% | |
| 23.0683% | |
| 35.4535% | |
| 1.1101% | |
| 12.7562% | |
| 18.6426% | |
| 30.004% | |
| 23.0355% | |
| 10.3754% | |
| 28.6779% | |
| 27.221% | |
| 20.0753% | |
| 18.4563% | |
| 15.0574% | |
| 3.5627% | |
| 17.9412% | |
| 5.8093% | |
| 14.9362% | |
| 11.561% | |
| 7.0921% | |
| 19.0569% | |
| 10.1189% | |
| 12.8931% | |
| -3.6538% | |
| 16.9377% | |
| 1.3901% | |
| -15.1944% | |
| -20.4134% | |
| 1.5432% | |
| -25.4583% | |
| -4.4572% | |
| 1.6159% | |
| 3.2343% | |
| 8.2121% | |
| 3.0736% | |
| 5.7291% | |
| 17.1411% | |
| 2.4401% | |
| -1.6538% | |
| -18.4578% | |
| -24.8116% | |
| -49.7098% | |
| -63.1877% | |
| -160.9131% | |
| -107.5981% | |
| -172.272% | |
| -51.8227% | |
| -128.1394% | |
| -255.6343% | |
| -194.7422% | |
| -222.4147% | |
| -158.7367% | |
| -205.1118% | |
| -128.0229% | |
| -150.4092% | |
| -75.3135% | |
| -151.7974% | |
| -137.1809% |